14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Dec 11, 2023 $6.57 $6.69 $6.25 $6.45 55 507
Dec 08, 2023 $6.91 $7.09 $6.46 $6.65 90 225
Dec 07, 2023 $6.71 $7.00 $6.67 $6.90 38 551
Dec 06, 2023 $6.83 $6.90 $6.41 $6.70 114 048
Dec 05, 2023 $7.00 $7.10 $6.77 $6.77 305 838
Dec 04, 2023 $6.58 $7.49 $6.52 $7.10 141 340
Dec 01, 2023 $6.05 $6.87 $5.58 $6.70 1 096 431
Nov 30, 2023 $6.08 $6.26 $5.74 $6.00 167 027
Nov 29, 2023 $6.11 $6.37 $5.90 $5.92 344 736
Nov 28, 2023 $6.39 $6.50 $5.91 $6.00 216 071
Nov 27, 2023 $6.74 $6.75 $6.33 $6.50 20 735
Nov 24, 2023 $6.62 $6.75 $6.54 $6.75 8 026
Nov 22, 2023 $6.57 $6.73 $6.42 $6.54 15 377
Nov 21, 2023 $6.83 $6.84 $6.38 $6.55 41 985
Nov 20, 2023 $7.04 $7.04 $6.72 $6.84 76 357
Nov 17, 2023 $7.06 $7.18 $6.26 $7.04 170 452
Nov 16, 2023 $7.35 $7.39 $6.86 $6.98 63 995
Nov 15, 2023 $7.48 $7.75 $7.20 $7.21 167 016
Nov 14, 2023 $6.48 $6.82 $6.33 $6.63 26 380
Nov 13, 2023 $6.09 $6.60 $5.78 $6.24 44 352
Nov 10, 2023 $6.21 $6.33 $6.08 $6.21 42 985
Nov 09, 2023 $6.70 $6.85 $6.02 $6.28 121 935
Nov 08, 2023 $7.07 $7.12 $6.56 $6.80 111 291
Nov 07, 2023 $7.00 $7.28 $6.95 $7.17 104 251
Nov 06, 2023 $7.23 $7.33 $6.83 $7.05 506 405
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT